Enteric immunization: Promises and challenges

Digestive Diseases

Volumn 14, Issue 3, 1996, Pages 192-200

  Brown, William R ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Antibodies; IgA; Immunization; Immunoglobulins; Lymphocytes; Peyer s patches; Vaccines

Indexed keywords

BACTERIAL VACCINE; VIRUS VACCINE;

ANIMAL; BACTERIAL INFECTION; DIARRHEA; ENTEROPATHY; HUMAN; IMMUNIZATION; METHODOLOGY; MUCOSAL IMMUNITY; ORAL DRUG ADMINISTRATION; RABBIT; REVIEW; VIRUS INFECTION;

ADMINISTRATION, ORAL; ANIMALS; BACTERIAL INFECTIONS; BACTERIAL VACCINES; DIARRHEA; HUMANS; IMMUNITY, MUCOSAL; IMMUNIZATION; INTESTINAL DISEASES; RABBITS; VIRAL VACCINES; VIRUS DISEASES;

EID: 0030133665     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000171550     Document Type: Article

References (41)

1. Trainor JJ, Mattison HR, Dumyati G, Yinnon A, Erb S, O'Brien D, Dolin R, Betts RF: Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly, Ann Intern Med 1992;117:625-633.
2. Strober W, Brown WR: The mucosal immune system; in Samter M, Talntage DW, Frank MM, Austen KF, Claman HN (eds): Immunological Diseases, ed 4, Boston, Little, Brown, 1988, pp 79-139.
3. Owen RL, Jones AL: Epithelial cell specialization within human Peyer’s patches: An ultrastructural study of intestinal lymphoid follicles, Gastroenterology 1974:66:189-203.
4. Tamaru T, Brown WR: IgA antibodies in rat bile inhibit cholera toxin-induced secretion in ileal loops in situ, Immunology 1985;55:579-583.
5. Williams RC, Gibbons RJ: Inhibition of bacterial adherence by secretory immunoglobulin A: A mechanism of antigen disposal, Science 1972;177:697-699.
6. Svanborg-Eden C, Svcnnerhom AM: Secretory immunoglobulin A and G antibodies prevent adhesion of Escherichia coli to human urinary tract epithelial cells, Infect Immun 1978;22:790-797.
7. Boedcker EC: Intestinal infection with Escherichia coli strain RDEC-1 in the rabbit: Pathogenesis and host immune responses: in Strober W, Lamm ME, McGhee JR, James SP (eds): Mucosal Immunity and Infections at Mucosal Surfaces, Oxford, Oxford University Press, 1988, pp 355-372.
8. Cantcy J: Prevention of bacterial infections of mucosal surfaces by immune IgA, Adv Exp Med Biol 1978;107:461-470.
9. Boedeker E, Cheney C, Cantey J: Inhibition of enteropathogenic Escherichia coli RDEC-1 adherence to rabbit intestinal brush borders by milk immunoglobulin IgA, Adv Exp Med Biol 1987;216B:911-918.
10. McQueen C, Shoham H, Boedeker E: Intragastric inoculation with an E, coli pilus attachment factor (AF/ Rl) protects against subsequent colonization by E, coli strain RDEC-1, Adv Exp Med Biol 1987;216B:911-918.
11. McQueen C, Boedeker E, Lc M, Ha-mada Y, Brown WR: The mucosal immune response to RDEC-I infection: Study of lamina propria antibody-producing cells and biliary antibody, Infect Immun 1992;60:206-212.
12. Walker RI: New strategies for using mucosal vaccination to achieve more effective immunization, Vaccine 1994:12:387-400.
13. Owen RL, Cray WC Jr., Ermak TH, Pierce NF: Bacterial characteristics and follicle surface structure: Their roles in Peyer’s patch uptake and transport of Vibrio cholerae: in Fos-sum S, Rolstad B (eds): Histophysi-ology of the Immune System, New York, Plenum, 1988, pp 705-715.
14. Owen RL, Pierce NF, Cray WC Jr.: Effects of bacterial inactivation methods, toxin production and oral immunization on uptake of Vibrio cholerae by Peyer’s patch lymphoid follicles: in Kmvahara S, Pierce NF (eds): Advances in Research on Cholera and Related Diarrheas, Tokyo, KTK Scientific Publishers, 1988, p 189.
15. Inman LR, Cantey JR: Peyer’s patch lymphoid follicle epithelial adherence of a rabbit enteropathogenic Escherichia coli strain: Role of plas-mid-nicdiatcd pili in initial adherence, J Clin Invest 1984:74:90-95.
16. de Aizpurua HJ, Russcll-Joncs GJ: Oral vaccinatio, Identification of classes of proteins that provoke an immune response upon oral feeding, I Exp Med 1988:167:440-451.
17. McKenzie SJ, Halsey JA: Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response, J Immunol 1984:133:1818-1824.
18. Morris W, Stcinhoff MC, Russell PK: Potential of polymer microencapsulation technology for vaccine innovation, Vaccine 1994:12:5-11.
19. McQueen CE, Bocdekcr EC, Reid R, Jarboe D, Wolf M, Le M, Brown WR: Pili in microsphercs protect rabbits from diarrhea induced by E, coli strain RDEC-I, Vaccine 1993;11:201-206.
20. Brown WR, Le M, Reid R, Bhagat H, BocdckerE: A histochcmical and immunohistochemical analysis of the uptake of microparticles by rabbit Peyer's patches: Uptake by both M cells and non-M cells, Gastroenterology 1993; 106:A657.
21. Boedeker E, Reid R, Baghat H, Dalai P, Tackett C, Losonsky G, Nataso J, Edelntan R, Levine M: Safety, im-munogenicity and efficacy in human volunteers of biodegradable, biocompatible microsphercs containing colonization factor antigen/ II as an enteral vaccine against enterotoxigenic E, coli, Gastroenterology 1993; 104:A672.
22. Eldridge JH, Gilley RM, Staas JK, Moldoveanu A, Mcalbrook JA, Tice TR: Biodegradable microsphercs: A vaccine delivery system for oral immunization, Curr Top Microbiol Immun 1989:146:59-62.
23. Marx PA, Compans RW, Gettie A, Staas JK, Gilley RM, Mulligan MJ, Yamashchikov GV, Chen D, Eldridge JH: Protection against vaginal S1V transmission with microencapsulated vaccine, Science 1993; 260:1323-1326.
24. Mestecky J, McGhee JR: Oral immunization: Past and present, Curr Top Microbiol Immunol 1989; 146: 3-11.
25. Michetti P, Mahan MJ, Slauch JM, Mekalanos JJ, Neutra MR: Monoclonal secretory immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella typhimurium, Infect Immun 1992;60:1786-1792.
26. Mekalanos JJ: Live attenuated vaccine vectors, Int J Technol 1994:10: 131-142.
27. Kotloff KL, Herrington DA, Hale TL, Newland JW, VadeVerg L, Co-gan JP, et al: Safety, immunogenici-ty, and efficacy in monkeys and humans of invasive Escherichia coli k-12 hybrid vaccine and humans of invasive Escherichia coli k-12 hybrid vaccine candidates expressing ShigellaJlexneri 2a somatic antigen, Infect Immun 1992;60:2218-2224.
28. Li A, Tiber P, Forsum U, Lindberg AA: Safety and immunogenicity of the live auxotrophic Shigella Jlexneri SFL124 in volunteers, Vaccine 1992:10:395-404.
29. Levine MM, Kaper JB, Herrington D, Ketley J, Losonsky G, Tacke CO, et al: Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD103 and CVD103-IlgR, Lancet 1988:ii:467-470.
30. Tacket CO, Losonsky G, Nataro JP, Cryz SJ, Edelntan R, Kaper JB, Levine MM: Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD103-HgR, J Infect Dis 1992; 166:837-841.
31. Sharyono X, Simanjuntak C, William N, Punjabi N, Hcppner DG, Losonsky G, et al: Safety and immunogenicity of single-dose live oral cholera vaccine CVD103-HgR in 5-to 9-year-old Indonesian children, Lancet 1992:340:689-694.
32. Ruby J, Ramsay A, Karuplah G, Ramshaw I: Recombinant virus vectors that coexpress cytokines - A new vaccine strategy, Vaccine Res 1992:1:347.
33. Mowal AM, Donachi AM: ISCOMS - A novel strategy from mucosal immunization? Immunol Today 1991; 12:383-386.
34. Walker RI, Clements JD: Use of heat-labile toxin of enterotoxigenic Escherichia coli to facilitate mucosal immunization, Vaccine Res 1993:2: 1-10.
35. Elson CO, Dcrtzbaugh MT: Mucosal adjuvants; in Ogra PL, Mestecky J, Lamm ME, Strober W, McGhee JR, Bienenstock J (eds): Handbook of Mucosal Immunology, San Diego, Academic Press, 1994, pp 391-410.
36. Wilson AD, Robinson A, Irons L, Stokes CR: Adjuvant action of cholera toxin and pertussis toxin in the induction of IgA antibody response to orally administered antigen, Vaccine 1993:11:113-118.
37. Lycke N, Holmgren J: Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens, Immunology 1986:59:301-308.
38. Liang X, Lamm ME, Ncdrus JG: Cholera toxin as a mucosal adjuvant, Glutaraldehyde treatment dissociates adjuvanticity form toxicity, J Immunol 1989:143:484-490.
39. Elson CO, Dcrtzbaugh MT: Mucosal adjuvants: in Ogra PL, Mestecky J, Lamm ME, Strober W, McGhee JR, Bienenstock J (eds): Handbook of Mucosal Immunology, San Diego, Academic Press, 1994, pp 391-410.
40. Svennerholm A-M, Hanson LA, Holmgren J, Lindlad BS, Milsson B, Quereshi F: Different secretory immunoglobulin A antibody responses to cholera vaccination in Swedish and Pakistani women, Infect Immun 1980;30:427-430.
41. Bloom L, Rowley D: Local immune response in mice to V, cholerac, Aust J Exp Biol Med Sci 1979;57: 313-323.